{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T12:34:58Z","timestamp":1794746098787,"version":"4.9.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Simple objective modalities are required for evaluating suspected autoimmune gastritis (AIG). This cross-sectional study aimed to examine whether pepsinogen, gastrin, and endoscopic findings can predict AIG. The diagnostic performance of endoscopic findings and serology in distinguishing AIG was evaluated. AIG was diagnosed in patients (N\u2009=\u200931) with anti-parietal cell antibody and\/or intrinsic factor antibody positivity and histological findings consistent with AIG. Non-AIG patients (N\u2009=\u2009301) were seronegative for anti-parietal cell antibodies. Receiver operating characteristic curve analysis of the entire cohort (N\u2009=\u2009332) identified an endoscopic atrophic grade cutoff point of O3 on the Kimura\u2013Takemoto classification (area under the curve [AUC]: 0.909), while those of pepsinogen-I, I\/II ratio, and gastrin were 20.1\u00a0ng\/mL (AUC: 0.932), 1.8 (AUC: 0.913), and 355\u00a0pg\/mL (AUC: 0.912), respectively. In severe atrophy cases (\u2265\u2009O3, N\u2009=\u200958, AIG\/control; 27\/31), the cutoff values of pepsinogen-I, I\/II ratio, and gastrin were 9.8\u00a0ng\/mL (AUC: 0.895), 1.8 (AUC: 0.86), and 355\u00a0pg\/mL (AUC: 0.897), respectively.\u00a0In conclusion, endoscopic atrophy is a predictor of AIG. High serum gastrin and low pepsinogen-I and I\/II ratio are predictors even in the case of severe atrophy, suggesting their usefulness when the diagnosis of AIG is difficult or as serological screening tests.<\/jats:p>","DOI":"10.1038\/s41598-022-07947-1","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T05:02:31Z","timestamp":1646888551000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Relevance of pepsinogen, gastrin, and endoscopic atrophy in the diagnosis of autoimmune gastritis"],"prefix":"10.1038","volume":"12","author":[{"given":"Hiroshi","family":"Kishikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Ojiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Arahata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakiko","family":"Takarabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichiro","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukie","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Hoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Kanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiro","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,10]]},"reference":[{"key":"7947_CR1","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/BF01071995","volume":"18","author":"RG Strickland","year":"1973","unstructured":"Strickland, R. G. & Mackay, I. R. A reappraisal of the nature and significance of chronic atrophic gastritis. Am. J. Dig. Dis. 18, 426\u2013440 (1973).","journal-title":"Am. J. Dig. Dis."},{"key":"7947_CR2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrgastro.2013.101","volume":"10","author":"WL Neumann","year":"2013","unstructured":"Neumann, W. L., Coss, E., Rugge, M. & Genta, R. M. Autoimmune atrophic gastritis\u2014pathogenesis, pathology and management. Nat. Rev. Gastroenterol. Hepatol. 10, 529\u2013541 (2013).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"7947_CR3","doi-asserted-by":"crossref","first-page":"12179","DOI":"10.3748\/wjg.v21.i42.12179","volume":"21","author":"I Coati","year":"2015","unstructured":"Coati, I. et al. Autoimmune gastritis: Pathologist\u2019s viewpoint. World J. Gastroenterol. 21, 12179\u201312189 (2015).","journal-title":"World J. Gastroenterol."},{"key":"7947_CR4","first-page":"67","volume":"32","author":"N Mahmud","year":"2019","unstructured":"Mahmud, N. et al. The incidence of neoplasia in patients with autoimmune metaplastic atrophic gastritis: A renewed call for surveillance. Ann. Gastroenterol. 32, 67\u201372 (2019).","journal-title":"Ann. Gastroenterol."},{"key":"7947_CR5","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/apt.15540","volume":"50","author":"E Miceli","year":"2019","unstructured":"Miceli, E. et al. Natural history of autoimmune atrophic gastritis: A prospective, single centre, long-term experience. Aliment. Pharmacol. Ther. 50, 1172\u20131180 (2019).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"7947_CR6","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1159\/000516624","volume":"102","author":"T Nishizawa","year":"2021","unstructured":"Nishizawa, T. et al. Clue of diagnosis for autoimmune gastritis. Digestion 102, 903\u2013910 (2021).","journal-title":"Digestion"},{"key":"7947_CR7","doi-asserted-by":"crossref","first-page":"e23264","DOI":"10.1002\/jcla.23264","volume":"34","author":"Y Guo","year":"2020","unstructured":"Guo, Y. et al. Analysis of clinical characteristics of 2243 with positive anti-gastric parietal cell antibody. J. Clin. Lab. Anal. 34, e23264 (2020).","journal-title":"J. Clin. Lab. Anal."},{"key":"7947_CR8","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1038\/ajg.2009.231","volume":"104","author":"E Lahner","year":"2009","unstructured":"Lahner, E. et al. Reassessment of intrinsic factor and parietal cell autoantibodies in atrophic gastritis with respect to cobalamin deficiency. Am. J. Gastroenterol. 104, 2071\u20132079 (2009).","journal-title":"Am. J. Gastroenterol."},{"key":"7947_CR9","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1080\/00365521.2017.1288758","volume":"52","author":"V Villanacci","year":"2017","unstructured":"Villanacci, V. et al. Autoimmune gastritis: Relationships with anemia and Helicobacter pylori status. Scand. J. Gastroenterol. 52, 674\u2013677 (2017).","journal-title":"Scand. J. Gastroenterol."},{"key":"7947_CR10","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/jclinpath-2015-203405","volume":"69","author":"M Venerito","year":"2016","unstructured":"Venerito, M. et al. Oxyntic gastric atrophy in Helicobacter pylori gastritis is distinct from autoimmune gastritis. J. Clin. Pathol. 69, 677\u2013685 (2016).","journal-title":"J. Clin. Pathol."},{"key":"7947_CR11","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/cen.12346","volume":"80","author":"KI Alexandraki","year":"2014","unstructured":"Alexandraki, K. I. et al. Are patients with autoimmune thyroid disease and autoimmune gastritis at risk of gastric neuroendocrine neoplasms type 1?. Clin. Endocrinol. (Oxf.) 80, 685\u2013690 (2014).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"7947_CR12","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.cgh.2012.02.018","volume":"10","author":"E Miceli","year":"2012","unstructured":"Miceli, E. et al. Common features of patients with autoimmune atrophic gastritis. Clin. Gastroenterol. Hepatol. 10, 812\u2013814 (2012).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"7947_CR13","doi-asserted-by":"crossref","first-page":"e12716","DOI":"10.1111\/hel.12716","volume":"25","author":"AM Demir","year":"2020","unstructured":"Demir, A. M. et al. Autoimmune atrophic gastritis: The role of Helicobacter pylori infection in children. Helicobacter 25, e12716 (2020).","journal-title":"Helicobacter"},{"key":"7947_CR14","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.2169\/internalmedicine.2693-19","volume":"58","author":"M Kawanaka","year":"2019","unstructured":"Kawanaka, M. et al. High prevalence of autoimmune gastritis in patients with nonalcoholic steatohepatitis. Intern. Med. 58, 2907\u20132913 (2019).","journal-title":"Intern. Med."},{"key":"7947_CR15","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1038\/ctg.2016.42","volume":"7","author":"V De Re","year":"2016","unstructured":"De Re, V. et al. Pepsinogens to distinguish patients with gastric intestinal metaplasia and Helicobacter pylori infection among populations at risk for gastric cancer. Clin. Transl. Gastroenterol. 7, e183 (2016).","journal-title":"Clin. Transl. Gastroenterol."},{"key":"7947_CR16","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.2169\/internalmedicine.2292-18","volume":"58","author":"T Notsu","year":"2019","unstructured":"Notsu, T. et al. Prevalence of autoimmune gastritis in individuals undergoing medical checkups in Japan. Intern. Med. 58, 1817\u20131823 (2019).","journal-title":"Intern. Med."},{"key":"7947_CR17","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/den.13500","volume":"32","author":"S Terao","year":"2020","unstructured":"Terao, S. et al. Multicenter study of autoimmune gastritis in Japan: Clinical and endoscopic characteristics. Dig. Endosc. 32, 364\u2013372 (2020).","journal-title":"Dig. Endosc."},{"key":"7947_CR18","doi-asserted-by":"publisher","DOI":"10.1111\/den.14175","author":"T Kamada","year":"2021","unstructured":"Kamada, T., Maruyama, Y., Monobe, Y. & Haruma, K. Endoscopic features and clinical importance of autoimmune gastritis. Dig. Endosc. https:\/\/doi.org\/10.1111\/den.14175 (2021).","journal-title":"Dig. Endosc."},{"key":"7947_CR19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000441742","volume":"93","author":"Y Yamaguchi","year":"2016","unstructured":"Yamaguchi, Y. et al. Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels\u2013The ABC method. Digestion 93, 13\u201318 (2016).","journal-title":"Digestion"},{"key":"7947_CR20","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.21873\/anticanres.11083","volume":"36","author":"K Syrj\u00e4nen","year":"2016","unstructured":"Syrj\u00e4nen, K. A panel of serum biomarkers (GastroPanel\u00ae) in non-invasive diagnosis of atrophic gastritis. Systematic review and meta-analysis. Anticancer Res. 36, 5133\u20135144 (2016).","journal-title":"Anticancer Res."},{"key":"7947_CR21","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.3390\/jcm8111992","volume":"8","author":"MV Lenti","year":"2019","unstructured":"Lenti, M. V. et al. Cell blood count alterations and patterns of anaemia in autoimmune atrophic gastritis at diagnosis: A multicentre study. J. Clin. Med. 8, 1992 (2019).","journal-title":"J. Clin. Med."},{"key":"7947_CR22","doi-asserted-by":"crossref","first-page":"e5784","DOI":"10.1097\/MD.0000000000005784","volume":"96","author":"M Carabotti","year":"2017","unstructured":"Carabotti, M. et al. Upper gastrointestinal symptoms in autoimmune gastritis: A cross-sectional study. Medicine 96, e5784 (2017).","journal-title":"Medicine"},{"key":"7947_CR23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000338295","volume":"86","author":"I Soykan","year":"2012","unstructured":"Soykan, I., Yakut, M., Keskin, O. & Bekta\u015f, M. Clinical profiles, endoscopic and laboratory features and associated factors in patients with autoimmune gastritis. Digestion 86, 20\u201326 (2012).","journal-title":"Digestion"},{"key":"7947_CR24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00535-004-1511-x","volume":"40","author":"Y Liu","year":"2005","unstructured":"Liu, Y., Uemura, N., Xiao, S. D., Tytgat, G. N. & Kate, F. J. Agreement between endoscopic and histological gastric atrophy scores. J. Gastroenterol. 40, 123\u2013127 (2005).","journal-title":"J. Gastroenterol."},{"key":"7947_CR25","doi-asserted-by":"crossref","first-page":"321","DOI":"10.5946\/ce.2019.072","volume":"52","author":"DT Quach","year":"2019","unstructured":"Quach, D. T. & Hiyama, T. Assessment of endoscopic gastric atrophy according to the Kimura-Takemoto classification and its potential application in daily practice. Clin. Endosc. 52, 321\u2013327 (2019).","journal-title":"Clin. Endosc."},{"key":"7947_CR26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/den.12964","volume":"30","author":"K Matsuda","year":"2018","unstructured":"Matsuda, K. et al. Design paper: Japan Endoscopy Database (JED): A prospective, large database project related to gastroenterological endoscopy in Japan. Dig. Endosc. 30, 5\u201319 (2018).","journal-title":"Dig. Endosc."},{"key":"7947_CR27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.autrev.2018.08.011","volume":"18","author":"S Massironi","year":"2019","unstructured":"Massironi, S., Zilli, A., Elvevi, A. & Invernizzi, P. The changing face of chronic autoimmune atrophic gastritis: An updated comprehensive perspective. Autoimmun. Rev. 18, 215\u2013222 (2019).","journal-title":"Autoimmun. Rev."},{"key":"7947_CR28","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1210\/jc.2007-0988","volume":"92","author":"S Checchi","year":"2007","unstructured":"Checchi, S. et al. Serum ghrelin as a marker of atrophic body gastritis in patients with parietal cell antibodies. J. Clin. Endocrinol. Metab. 92, 4346\u20134351 (2007).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"7947_CR29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3109\/00365529109103998","volume":"186","author":"K Varis","year":"1991","unstructured":"Varis, K., Kekki, M., H\u00e4rk\u00f6nen, M., Sipponen, P. & Samloff, I. M. Serum pepsinogen I and serum gastrin in the screening of atrophic pangastritis with high risk of gastric cancer. Scand. J. Gastroenterol. Suppl. 186, 117\u2013123 (1991).","journal-title":"Scand. J. Gastroenterol. Suppl."},{"key":"7947_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2020-139183","author":"DO Koc","year":"2020","unstructured":"Koc, D. O. & Bektas, S. Serum pepsinogen levels and OLGA\/OLGIM staging in the assessment of atrophic gastritis types. Postgrad. Med J. https:\/\/doi.org\/10.1136\/postgradmedj-2020-139183 (2020).","journal-title":"Postgrad. Med J."},{"key":"7947_CR31","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/MCG.0000000000000101","volume":"49","author":"E Miceli","year":"2015","unstructured":"Miceli, E. et al. A laboratory score in the diagnosis of autoimmune atrophic gastritis: A prospective study. J. Clin. Gastroenterol. 49, e1\u2013e5 (2015).","journal-title":"J. Clin. Gastroenterol."},{"key":"7947_CR32","doi-asserted-by":"crossref","first-page":"e00240","DOI":"10.14309\/ctg.0000000000000240","volume":"11","author":"E Lahner","year":"2020","unstructured":"Lahner, E. et al. Autoantibodies toward ATP4A and ATP4B subunits of gastric proton pump H+, K+ ATPase are reliable serological pre-endoscopic markers of corpus atrophic gastritis. Clin. Transl. Gastroenterol. 11, e00240 (2020).","journal-title":"Clin. Transl. Gastroenterol."},{"key":"7947_CR33","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000484217","volume":"97","author":"Y Kojima","year":"2018","unstructured":"Kojima, Y. et al. Does the novel potassium-competitive acid blocker vonoprazan cause more hypergastrinemia than conventional proton pump inhibitors? A multicenter prospective cross-sectional study. Digestion 97, 70\u201375 (2018).","journal-title":"Digestion"},{"key":"7947_CR34","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000484688","volume":"97","author":"A Shiotani","year":"2018","unstructured":"Shiotani, A. et al. Hypergastrinemia in long-term use of proton pump inhibitors. Digestion 97, 154\u2013162 (2018).","journal-title":"Digestion"},{"key":"7947_CR35","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.clinre.2012.09.013","volume":"37","author":"M Yakut","year":"2013","unstructured":"Yakut, M. et al. The association between precancerous gastric lesions and serum pepsinogens, serum gastrin, vascular endothelial growth factor, serum interleukin-1 beta, serum toll-like receptor-4 levels and Helicobacter pylori Cag A status. Clin. Res. Hepatol. Gastroenterol. 37, 302\u2013311 (2013).","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"7947_CR36","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000469705","volume":"95","author":"H Kishikawa","year":"2017","unstructured":"Kishikawa, H. et al. Cutoff pepsinogen level for predicting unintendedly eradicated cases of Helicobacter pylori infection in subjects with seemingly normal pepsinogen levels. Digestion 95, 229\u2013236 (2017).","journal-title":"Digestion"},{"key":"7947_CR37","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1080\/00365521.2021.2002927","volume":"57","author":"N Sumi","year":"2022","unstructured":"Sumi, N. et al. Diagnosis of histological gastritis based on the Kyoto classification of gastritis in Japanese subjects\u2013including evaluation of aging and sex difference of histological gastritis. Scand. J. Gastroenterol. 57, 260\u2013265 (2022).","journal-title":"Scand. J. Gastroenterol."},{"key":"7947_CR38","doi-asserted-by":"crossref","first-page":"156719","DOI":"10.1155\/2015\/156719","volume":"2015","author":"H Kishikawa","year":"2015","unstructured":"Kishikawa, H., Kimura, K., Takarabe, S., Kaida, S. & Nishida, J. Helicobacter pylori antibody titer and gastric cancer screening. Dis. Markers 2015, 156719 (2015).","journal-title":"Dis. Markers"},{"key":"7947_CR39","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1158\/1055-9965.EPI-19-0993","volume":"29","author":"M Inoue","year":"2020","unstructured":"Inoue, M. et al. High-negative anti-Helicobacter pylori IgG antibody titers and long-term risk of gastric cancer: Results from a large-scale population-based cohort study in Japan. Cancer Epidemiol. Biomark. Prev. 29, 420\u2013426 (2020).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"7947_CR40","doi-asserted-by":"crossref","first-page":"e12669","DOI":"10.1111\/hel.12669","volume":"25","author":"H Kishikawa","year":"2020","unstructured":"Kishikawa, H. et al. Previous Helicobacter pylori infection\u2013induced atrophic gastritis: A distinct disease entity in an understudied population without a history of eradication. Helicobacter 25, e12669 (2020).","journal-title":"Helicobacter"},{"key":"7947_CR41","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0889-8553(05)70156-4","volume":"29","author":"DY Graham","year":"2000","unstructured":"Graham, D. Y. & Klein, P. D. Accurate diagnosis of Helicobacter pylori. 13C-urea breath test. Gastroenterol. Clin. North Am. 29, 885\u2013893 (2000).","journal-title":"Gastroenterol. Clin. North Am."},{"key":"7947_CR42","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1055\/s-0028-1098086","volume":"1","author":"K Kimura","year":"1969","unstructured":"Kimura, K. & Takemoto, T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1, 87\u201397 (1969).","journal-title":"Endoscopy"},{"key":"7947_CR43","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis, J. R. & Koch, G. G. The measurement of observer agreement for categorical data. Biometrics 33, 159\u2013174 (1977).","journal-title":"Biometrics"},{"key":"7947_CR44","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda, Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant. 48, 452\u2013458 (2013).","journal-title":"Bone Marrow Transplant."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-07947-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-07947-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-07947-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T12:19:23Z","timestamp":1700309963000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-07947-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,10]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["7947"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-07947-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,10]]},"assertion":[{"value":"22 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4202"}}